Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis

Overview of attention for article published in Dermatology and Therapy, October 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 24 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,182 followers.

Our paper "Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis” has been published in Dermatology and Therapy! https://t.co/9UDUVSOGpG #atopicdermatitis #Dupilumab

In this study authors report the long-term changes in symptoms and QoL as well as patient assessment of treatment effect in adults with moderate-to-severe #AtopicDermatitis treated for 2 years with #dupilumab in an OLE study (LIBERTY AD OLE): https://t.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.